13C Urease Test: Preparation, Results, and Interpretation

The 13C-urea breath test is a noninvasive method for detecting active Helicobacter pylori infection. Its value lies in its confirmation of the presence of live bacteria with urease activity, rather than traces of past exposure, as is the case with serological antibody tests. The 2024 US guidelines list the breath test and the Helicobacter pylori stool antigen test as the primary noninvasive methods for diagnosing active infection and specifically recommend avoiding serology for confirming current infection and monitoring cure. [1]

The significance of Helicobacter pylori extends far beyond simple dyspepsia. Guidelines from the American College of Gastroenterology emphasize that the infection is causally linked to gastric cancer and is considered a key modifiable risk factor for some patients. Therefore, accurate diagnosis and mandatory confirmation of eradication after treatment are now considered standard rather than optional. [2]

The test mechanism is based on the ability of Helicobacter pylori to break down urea with the enzyme urease. The patient ingests urea labeled with the stable isotope carbon 13, which, in the presence of the bacteria, produces 13C-carbon dioxide, which is absorbed into the blood and excreted through the lungs. The laboratory then compares the initial and post-exercise exhaled breath samples and calculates the increase in the indicator relative to background. [3]

The European Guidelines for 13C Breath Testing emphasize that the delta over baseline value is typically used for the 13C urease test, and for most established protocols, the value 30 minutes after ingestion of the labeled urea is decisive. This is important for the correct reading of the form: the laboratory is essentially assessing the magnitude of the increase in 13C in the exhaled breath compared to the baseline level. [4]

When properly prepared, the 13C-urease test has very high diagnostic accuracy. A European consensus indicates that for most adult protocols, with a threshold above 4‰ and a sample analyzed within 30 minutes, the pooled sensitivity and specificity, based on 10 studies, were approximately 0.95 and 0.95, respectively. It is one of the best direct noninvasive tests for detecting active infection. [5]

Table 1. What the 13C-urease test shows

Question	Answer
Does the test detect active infection?	Yes
Is it suitable for primary non-invasive diagnostics in adults?	Yes
Is it suitable for monitoring cure?	Yes
Does it show antibodies after an infection?	No
Does it allow you to see an ulcer, atrophy or tumor?	No
Does it provide information about the sensitivity of Helicobacter pylori to antibiotics?	No

The table is based on the recommendations of the American College of Gastroenterology, the British Standard for Test Preparation and the European Consensus on 13C Breath Testing.[6]

When is a 13C urease test prescribed?

In adults, the test is prescribed when it is necessary to confirm active Helicobacter pylori infection non-invasively. The summary of the 2024 American College of Gastroenterology guidelines lists the main clinical situations in which testing makes sense: current or past peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, dyspepsia in patients under 60 years of age, functional dyspepsia, long-term use of nonsteroidal anti-inflammatory drugs or aspirin, iron deficiency anemia of unknown origin, idiopathic thrombocytopenic purpura, as well as premalignant conditions of the stomach and groups at high risk of gastric cancer. [7]

The key modern principle is that testing should be reserved for those who, if positive, will be offered treatment, and that eradication should be confirmed after treatment. The 2024 guidelines explicitly state that all patients diagnosed and treated for Helicobacter pylori should then undergo a cure test using a properly performed breath test, a stool antigen test, or a biopsy. [8]

For outpatient practice, the 13C-urease test is particularly convenient where immediate endoscopy is not necessary. It does not require a biopsy, is more easily tolerated than most invasive procedures, and provides a quick answer to the question of whether an active infection is present. Therefore, in real-world practice, it often competes with the Helicobacter pylori stool antigen test rather than endoscopy. [9]

For children, the approach is different. The 2024 joint guidelines of the European and North American Societies of Pediatric Gastroenterology specifically emphasize that in children, there is no evidence base to support a "find and treat" strategy without a full clinical assessment, and in cases of functional abdominal pain without warning signs, testing for Helicobacter pylori is not indicated at all. This fundamentally distinguishes pediatric practice from adult practice. [10]

Therefore, the 13C-urease test cannot be considered a universal answer to any upper abdominal discomfort. It is useful when the question is clearly posed: is there an active Helicobacter pylori infection and should it be treated, or has the treatment already been successful? Outside of these contexts, even a highly accurate test can easily be misused. [11]

Table 2. When the 13C-urease test is appropriate and when it is not

Situation	The role of the test
Dyspepsia in an adult under 60 years of age without immediate need for endoscopy	Often appropriate
Suspected peptic ulcer disease and the need for non-invasive confirmation of Helicobacter pylori	Appropriate
Monitoring of recovery after therapy	Required or one of the preferred options
Functional abdominal pain in a child without alarming signs	Not usually shown
The need for antibiotic susceptibility testing	Doesn't solve the problem
The need to see the gastric mucosa and take a biopsy	Does not replace endoscopy

The table summarizes the positions of the adult and child recommendations for 2024. [12]

Preparation for the 13C-urease test

The accuracy of a breath test depends almost as much on preparation as on the quality of the equipment. The main rule is to eliminate factors that temporarily suppress Helicobacter pylori or alter stomach conditions so much that the bacteria become "invisible" to the test. This is why modern guidelines specifically regulate the discontinuation of medications before the test. [13]

Proton pump inhibitors should be discontinued at least 2 weeks prior to testing. The British quality standard for Helicobacter pylori testing specifically requires a 2-week "window" without these drugs, and the 2024 US guidelines specifically warn that they increase the risk of false-negative results. [14]

Antibiotics and bismuth-containing medications should be discontinued at least 4 weeks prior to treatment. This recommendation is repeated in several relevant sources and applies to both adults and children. The reason is simple: both antibiotics and bismuth can temporarily suppress the bacterial load and create a false sense of the absence of infection. [15]

Antacids are not considered a significant source of error for breath testing. In children, recommendations allow for a temporary switch to a histamine type 2 receptor antagonist if a 2-week withdrawal of acid-reducing therapy is poorly tolerated, but it is advisable to discontinue this medication 2 days before the test. This is an important detail that is often omitted from brief information sheets. [16]

In addition to discontinuing medications, dietary restrictions should be observed. The European consensus recommends that adults perform the test after an overnight fast, or if this is not possible, after a fast of at least 4-6 hours; for children of all ages, 4 hours is usually sufficient. Physical activity should be avoided during the test itself, as even moderate exercise significantly alters carbon dioxide production and can distort the results. [17]

Table 3. Step-by-step preparation for the test

What needs to be done	Term
Discontinue proton pump inhibitors	Minimum 2 weeks in advance
Stop antibiotics	Minimum 4 weeks in advance
Discontinue bismuth preparations	Minimum 4 weeks in advance
Antacids	Usually acceptable
A histamine type 2 receptor blocker in a child as a temporary replacement	Possible, but it is advisable to cancel 2 days before the test.
Fasting in an adult	Ideally overnight, minimum 4-6 hours
Fasting in a child	Usually 4 hours
Physical activity during the test	Avoid

This table is based on the American College of Gastroenterology guidelines, the NICE standard, and the 2024 pediatric guidelines.[18]

How does the procedure work?

The procedure typically consists of two stages of breath sampling. First, a baseline exhaled breath sample is collected to determine the background ratio of 13C to 12C. The patient then ingests labeled urea, after which, after a specified time, a second sample is collected and compared with the background. [19]

In many standardized protocols, labeled urea is administered with citric acid solution. The European consensus states that most studies used 13C-urea with citrate solution, and that the use of other media, such as orange juice, may alter sensitivity. In other words, the accuracy of the test depends not only on the urea itself but also on the specific protocol. [20]

For most adult protocols, the sample collected 30 minutes after ingestion of labeled urea is considered decisive. This approach has accumulated the most data on diagnostic accuracy, and it is the basis for many laboratory thresholds. Modifications to the protocol are possible for children, but the principle remains the same: comparing the initial exhaled breath with the exhaled breath after contact of the labeled urea with gastric urease. [21]

The result on the form is usually expressed as an increase relative to the baseline, or delta over baseline. This is not a "percentage of infection" or "number of bacteria in the stomach," but a laboratory indicator reflecting the increase in 13C-carbon dioxide excretion after exercise. Therefore, comparing forms from different laboratories using the same number without knowing the protocol is not always accurate. [22]

For most adult protocols, a threshold above 4‰ after 30 minutes is most commonly used, and at this threshold, the combined sensitivity and specificity in a European review were close to 95%. However, this does not mean that every form in all laboratories worldwide will have exactly this threshold: the final interpretation is always made according to the reference value of a specific test system and a specific laboratory. [23]

Table 4. How the study is conducted

Stage	What's happening
1	A baseline sample of exhaled air is taken
2	The patient takes 13C-labeled urea
3	A number of protocols use a citric acid solution.
4	After a set time, usually 30 minutes for adults, a repeat sample is taken.
5	The laboratory calculates the increase in 13C relative to the background
6	The result is compared with the threshold of a specific test system.

The structure of the procedure and key parameters are based on the European consensus on 13C breath tests. [24]

How to understand a positive and negative result

A positive result indicates that after taking 13C-urea, an increase in 13C-carbon dioxide in the exhaled air was recorded above the established threshold. With proper preparation, this is considered a high probability of an active Helicobacter pylori infection. The clinical significance of this result is that this is not a case of "old antibodies," but rather a live infection requiring treatment considerations. [25]

A negative result usually means that an active infection is unlikely. But the key word here is "with proper preparation." If the patient took a proton pump inhibitor, antibiotics, or bismuth too close to the test date, a negative result is no longer truly reliable and may turn out to be a false negative. [26]

If the result doesn't match the clinical picture, don't rely solely on the paperwork. Since current guidelines recognize the 13C-urease test and the Helicobacter pylori antigen test in feces as suitable direct, non-invasive methods for diagnosing active infection and confirming cure, when in doubt, the physician will typically either repeat the breath test according to the guidelines or use an alternative direct test. This isn't a sign of a "bad" test, but rather normal clinical logic. [27]

It's important to understand that a breath test is not intended to assess the degree of gastritis, atrophy, intestinal metaplasia, or the risk of bleeding immediately. It only answers the question of the presence of active Helicobacter pylori infection. If the clinical situation requires visualization of the gastric mucosa, a biopsy, or obtaining material for antibiotic susceptibility testing, a breath test alone is not sufficient. [28]

This is why the interpretation of the result should always be clinical, not formal. A positive test without understanding the reason for treatment and how eradication should be monitored is of little use. A negative test without taking into account medications and preparation times can also be misleading. The form itself is important, but it does not replace a medical decision. [29]

Table 5. How to interpret the result

Result	What does it mean?	What to do next
Positive	Active infection is likely	Discuss the eradication regimen and subsequent monitoring of cure
Negative with proper preparation	Active infection is unlikely	Look for another cause of symptoms or act according to the clinical situation
Negative after recent use of a proton pump inhibitor, antibiotics, or bismuth	A false negative result is possible	Repeat the test after proper preparation
Questionable or clinically inconsistent result	Requires re-checking	Repeat the test according to the protocol or use another direct test

The table is based on the principles outlined in the 2024 Helicobacter pylori guidelines and the European 13C breath test guidelines.[30]

Post-treatment test and main sources of errors

After eradication therapy, the 13C-urease test plays a special role because it helps determine whether the infection has truly cleared. The 2024 American guidelines require confirmation of cure in all treated patients and perform this test no earlier than 4 weeks after completing antibiotics and no earlier than 2 weeks after discontinuing proton pump inhibitors or potassium-competitive acid blockers. [31]

The timeframe varies among children. The 2024 Joint Pediatric Guidelines recommend the 13C-urease test and the two-stage monoclonal Helicobacter pylori antigen test in feces as the preferred methods for monitoring cure and recommend testing 6–8 weeks after completion of therapy to avoid false-negative results from testing too early and to avoid confusing a late positive result with reinfection. [32]

The main cause of false-negative results is improper preparation. Proton pump inhibitors, antibiotics, and bismuth reduce the bacterial load and urease activity, which can temporarily make Helicobacter pylori "invisible" to the test. Pediatric guidelines specifically emphasize that these factors can cause false-negative results in all diagnostic methods. [33]

There is another peculiarity in young children. Pediatric guidelines warn that in children under 6 years of age, the 13C-urease test may yield false-positive results due to a smaller distribution volume, different carbon dioxide production, and technical difficulties in performing it, including problems with swallowing the substrate and the influence of urease in the oral cavity. This is a crucial difference from adult practice. [34]

There are also conceptual limitations. A breath test does not provide information on the susceptibility of Helicobacter pylori to antibiotics, and therefore does not help in choosing a rescue regimen after unsuccessful therapy. In such cases, endoscopy, biopsy, culture, and other methods are needed that allow one to go beyond the simple answer of "infection or not." [35]

Table 6. The most common causes of erroneous results

Cause	What type of error is more likely?	Why
Proton pump inhibitors less than 2 weeks before the test	False negative	Bacterial activity decreases and conditions in the stomach change
Antibiotics less than 4 weeks before the test	False negative	Temporarily suppress Helicobacter pylori
Bismuth preparations less than 4 weeks before the test	False negative	Suppress bacterial load
Insufficient fasting	Loss of accuracy is possible	The conditions of contact between the substrate and the mucous membrane change
Physical activity during the test	Loss of accuracy is possible	Carbon dioxide production is changing
Child's age up to 6 years	False positive is possible	Age-related physiological and technical characteristics

The table is compiled based on data from adult and pediatric recommendations and the European consensus on the performance of 13C breath tests. [36]

Comparison with other methods and special situations

In practice, the 13C-urease test is most often compared with the Helicobacter pylori antigen test in feces. Both methods are considered direct, noninvasive tests for active infection, and both are suitable for monitoring cure after treatment. The choice between them is usually determined by availability, laboratory organization, patient preference, and age, rather than by the fact that one method is "very good" and the other "bad." [37]

Serological tests are a separate category. Both adult and pediatric guidelines warn that antibodies in serum, whole blood, urine, or saliva are not suitable for reliably confirming active Helicobacter pylori infection, much less assessing treatment success. This is because antibodies can persist long after the bacteria have disappeared. [38]

In children, the 13C-urease test should not replace a comprehensive diagnostic strategy. Pediatric guidelines clearly state that the goal of examining a child with gastrointestinal symptoms is to find the cause of the complaints, not simply to "catch Helicobacter pylori." Therefore, initial diagnosis, when clinically necessary, should rely on endoscopy with biopsy methods, and not solely on a breath test or stool examination. [39]

Pregnancy deserves special mention. The 13C isotope itself is non-radioactive, which is a significant advantage of this method compared to traditional 14C approaches. However, specific instructions for individual commercial kits may formulate the question of use during pregnancy and lactation differently, so in real-world practice, the decision should be made based on the local protocol and instructions for the specific test system used in the clinic. [40]

The main practical conclusion is simple: the 13C-urease test is a very powerful tool when prescribed according to indications and performed correctly. But it is not a "test for everything," not a replacement for endoscopy, and not a way to determine an antibiotic regimen. Its purpose is narrower, but within that purpose, it truly is one of the best modern methods. [41]

Table 7. 13C

Method	Active infection	Cure control	Preparation with discontinuation of proton pump inhibitors is required.	Shows the gastric mucosa	Provides data on antibiotic susceptibility
13C-urease test	Yes	Yes	Yes	No	No
Helicobacter pylori stool antigen test	Yes	Yes	Yes	No	No
Serology	Limited	No	No, just like for the breath test.	No	No
Endoscopy with biopsy methods	Yes	Can be used	Preparation is determined by the clinical task	Yes	Partially, if culture and further investigations are performed

The comparison reflects current adult and pediatric recommendations for Helicobacter pylori. [42]

Practical conclusions

The 13C-urea breath test is one of the most accurate, direct, non-invasive ways to confirm active Helicobacter pylori infection and one of the preferred methods for checking treatment success. Its strength lies in its combination of high accuracy, safety, and outpatient convenience. [43]

The key to reliable results is proper preparation. Failure to discontinue proton pump inhibitors for at least two weeks, antibiotics, and bismuth for at least four weeks, and the required fasting period may result in a false negative result. In practice, this is the most common cause of diagnostic errors. [44]

For adults, post-treatment follow-up is performed no earlier than 4 weeks after antibiotics and 2 weeks after discontinuing acid-reducing therapy. For children, the benchmark is stricter—usually 6-8 weeks after completing the course. These differences must be taken into account, otherwise the same test will be interpreted incorrectly. [45]

A positive result usually indicates an active infection, while a negative result indicates a low probability, but only if the protocol is followed correctly. If the result is inconsistent with the clinical picture, a recheck with a direct test is required, rather than attempting to explain it all away as "bad lab work" or "unimportant numbers." [46]

From a practical standpoint, the question for the 13C-urease test should be: is there currently an active Helicobacter pylori infection and has it resolved after treatment? The method answers these two questions very well. It doesn't answer all the other questions, and this isn't a drawback, but rather the limit of its competence. [47]

FAQ

Does the 13C-urease test indicate a past or current infection?
The test specifically identifies a current, active Helicobacter pylori infection because it is based on the urease activity of live bacteria. This is its fundamental difference from serology. [48]

Should proton pump inhibitors be discontinued before the test?
Yes. Current recommendations call for discontinuation at least two weeks beforehand, otherwise the risk of a false-negative result increases. [49]

Should antibiotics and bismuth be discontinued?
Yes. Both antibiotics and bismuth should be discontinued at least 4 weeks before the study. [50]

Can the test be performed immediately after treatment?
No. In adults, confirmation of cure is performed no earlier than 4 weeks after finishing antibiotics and after 2 weeks without proton pump inhibitors. In children, the test is usually performed 6-8 weeks after treatment. [51]

Which is better: a breath test or a stool antigen test?
Both methods are suitable for detecting active infection and monitoring recovery. The choice depends on availability and the clinical situation. [52]

Can a breath test tell you which antibiotics will work?
No. Assessing susceptibility requires invasive methods, such as a biopsy with culture and additional testing. [53]

Are false negatives possible?
Yes, most often with recent use of proton pump inhibitors, antibiotics, or bismuth, as well as if testing is performed too early after treatment. [54]

Is the test suitable for children?
Yes, but with some caveats. It's an important method for children, especially for monitoring progress, but it doesn't support a "find and treat" strategy for functional pain without warning signs, and false-positive results are possible in children under 6 years of age. [55]

Is the test safe during pregnancy?
The isotope 13C is not radioactive, but the wording of instructions for specific kits varies, so the decision is made based on local protocol and the instructions for the test system being used. [56]